The FDA granted orphan designation to Sanofi US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Discover th ...
In a recent study, non-invasive prenatal testing was able to help researchers diagnose fetal anemia earlier during pregnancy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback